Related Experiment Videos

Recent advances in medical oncology--1995-1996

¹Brown University School of Medicine, Providence, RI 02906, USA.

Medicine and Health, Rhode Island

|March 1, 1996

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Long-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data from BrighTNess, a randomized phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2022

Neoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer: a Brown University Oncology Research Group (BrUOG) study.

Breast cancer research and treatment·2021

SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer.

Breast cancer research and treatment·2016

Locally advanced breast cancer.

Current treatment options in oncology·2002

Splenosis presenting as occult gastrointestinal bleeding.

American journal of hematology·2000

Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia.

American journal of hematology·1999

See all related articles